MYADMIA

Serial Number 97587826
Registration 7484496
700

Registration Progress

Application Filed
Sep 12, 2022
Under Examination
Approved for Publication
Jun 11, 2024
Published for Opposition
Jun 11, 2024
Registered
Aug 27, 2024

Trademark Image

MYADMIA

Basic Information

Serial Number
97587826
Registration Number
7484496
Filing Date
September 12, 2022
Registration Date
August 27, 2024
Published for Opposition
June 11, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 27, 2024
Registration
Registered
Classes
005

Rights Holder

Takeda Pharmaceuticals International AG

99
Address
Thurgauerstrasse 130
Glattpark-Opfikon 8152
CH

Ownership History

Takeda Pharmaceuticals International AG

Original Applicant
99
Glattpark-Opfikon CH

Takeda Pharmaceuticals International AG

Owner at Publication
99
Glattpark-Opfikon CH

Takeda Pharmaceuticals International AG

Original Registrant
99
Glattpark-Opfikon CH

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

Next Deadline
1856 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-08-27)
Due Date
August 27, 2030
Grace Period Ends
February 27, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Aug 27, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 27, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 11, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 11, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 22, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 7, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 7, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 6, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 6, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 1, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 1, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 1, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 27, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 27, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 27, 2024 ALIE A ASSIGNED TO LIE Loading...
Nov 8, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 14, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Sep 14, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jun 24, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 24, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 24, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 24, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 29, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 15, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, preparations for enzyme replacement therapy for thrombotic disorders; Pharmaceutical preparations for treatment of thrombotic disorders by means of enzyme replacement therapy

Classification

International Classes
005